glp-1 and colonoscopy Quality of bowel preparation for in patients on glucagon-like peptide-1 receptor agonists GLP-1 Receptor Agonists and Gastrointestinal

Multidisciplinary support is crucial and may include: Dietetic input to establish regular, balanced eating patterns without rigid restriction Specialist eating disorder services for complex presentations Support groups (such as Beat, the UK eating disorder charity) Treatment of co-occurring conditions such as depression, anxiety, or substance use disorders Patients should be encouraged to access NHS talking therapies through self-referral or GP referral

Glp1r-Lepr coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1/ leptin dual agonist

No further liquid was allowed from 2 h before until 2 h after dosing, with no subsequent restrictions on liquid or food ingestion until the next pre-dose fasting period

In addition, these therapies work by enhancing insulin secretion and slowing gastric emptying

GLP-1 Pipeline Update: May 2026 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior, Pipeline DISCLAIMER The drug pipeline is fluid

These agents mimic the action of endogenous GLP-1, an incretin hormone released from intestinal L-cells in response to nutrient intake